TY - JOUR
T1 - The effect of an expiratory resistance mask with dead space on sleep, acute mountain sickness, cognition, and ventilatory acclimatization in normobaric hypoxia
AU - Patrician, Alexander
AU - Tymko, Michael M
AU - Caldwell, Hannah Grace
AU - Howe, Connor A
AU - Coombs, Geoff B
AU - Stone, Rachel
AU - Hamilton, Allison
AU - Hoiland, Ryan L
AU - Ainslie, Philip N
N1 - (Ekstern)
PY - 2019
Y1 - 2019
N2 - We examined the hypothesis that an expiratory resistance mask containing a small amount of dead space (ER/DS) would reduce the apnea-hypopnea index (AHI) during sleep, attenuate the severity of acute mountain sickness (AMS), and offset decrements in cognitive function compared with a sham mask. In a double-blinded, randomized, sham-controlled, crossover design, 19 volunteers were exposed to two nights of normobaric hypoxia (F I O 2 = 0.125), using a ER/DS mask (3.5 mm restrictive expiratory orifice; 125 mL DS volume) and sham mask (zero-flow resistance; 50 mL DS volume). Cognitive function, AMS, and ventilatory acclimatization were assessed before and after the 12-hour normobaric hypoxia exposure. Polysomnography was conducted during sleep. AHI was reduced using the ER/DS sleep mask compared with the sham (30.1 ± 23.9 eventshr -1 vs. 58.9 ± 34.4 eventshr -1 , respectively; p = 0.01). Likewise, oxygen desaturation index and headache severity were reduced (both p < 0.05). There were also benefits on limiting the hypoxia-induced reductions in select measures of reaction speed and attention (p < 0.05). Our study indicates that a simple noninvasive and portable ER/DS mask resulted in reductions (49%) in AHI, and reduced headache severity and aspects of cognitive decline. The field applications of this ER/DS mask should be investigated before recommendations can be made to support its benefit for travel to high altitude.
AB - We examined the hypothesis that an expiratory resistance mask containing a small amount of dead space (ER/DS) would reduce the apnea-hypopnea index (AHI) during sleep, attenuate the severity of acute mountain sickness (AMS), and offset decrements in cognitive function compared with a sham mask. In a double-blinded, randomized, sham-controlled, crossover design, 19 volunteers were exposed to two nights of normobaric hypoxia (F I O 2 = 0.125), using a ER/DS mask (3.5 mm restrictive expiratory orifice; 125 mL DS volume) and sham mask (zero-flow resistance; 50 mL DS volume). Cognitive function, AMS, and ventilatory acclimatization were assessed before and after the 12-hour normobaric hypoxia exposure. Polysomnography was conducted during sleep. AHI was reduced using the ER/DS sleep mask compared with the sham (30.1 ± 23.9 eventshr -1 vs. 58.9 ± 34.4 eventshr -1 , respectively; p = 0.01). Likewise, oxygen desaturation index and headache severity were reduced (both p < 0.05). There were also benefits on limiting the hypoxia-induced reductions in select measures of reaction speed and attention (p < 0.05). Our study indicates that a simple noninvasive and portable ER/DS mask resulted in reductions (49%) in AHI, and reduced headache severity and aspects of cognitive decline. The field applications of this ER/DS mask should be investigated before recommendations can be made to support its benefit for travel to high altitude.
KW - Altitude illness
KW - Cognitive function
KW - Hypoxia
KW - Sleep
UR - http://www.scopus.com/inward/record.url?scp=85063214167&partnerID=8YFLogxK
U2 - 10.1089/ham.2018.0074
DO - 10.1089/ham.2018.0074
M3 - Journal article
C2 - 30720346
AN - SCOPUS:85063214167
VL - 20
SP - 61
EP - 70
JO - High Altitude Medicine and Biology (Print)
JF - High Altitude Medicine and Biology (Print)
SN - 1527-0297
IS - 1
ER -